Search

everythinglearnresearchcommunity

for

Search:↓

iPSCs show promise for hair regeneration but need more research to improve reliability and effectiveness.

Many LGBTQ individuals in Lahore face skin issues, with androgenic alopecia, dry skin, and scabies being common, highlighting the need for better healthcare access and provider training.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Combining therapy, behavior techniques, and medication can help manage trichotillomania and depression.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Estrogen therapy can reduce skin aging but has cancer risks.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

No single treatment is clearly effective for central serous chorioretinopathy.

Personalized acne treatments and new therapies show promise for better results.

Mesotherapy is a skin injection therapy used for pain and local conditions, with scientific support but needing more clinical trials.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

PRP therapy increases hair density for androgenetic alopecia.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Testosterone's effects on COVID-19 are unclear and need more research.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.